
pmid: 20219638
Dopamine has long held a prominent role in the interpretation of schizophrenia and other psychoses. Clinical studies on confabulation and disorientation, disorders marked by a confusion of reality in thinking, indicated that the ability to keep thinking in phase with reality depends on a process suppressing the interference of upcoming memories that do not refer to ongoing reality. A host of animal studies and a recent clinical study suggested that this suppression might correspond to the phasic inhibition of dopaminergic neurons in response to the absence of expected outcomes. In this study, we tested healthy subjects with a difficult version of a memory paradigm on which confabulating patients had failed. Subjects participated in three test sessions, in which they received in double-blind, randomized fashion L-dopa, risperidone, or placebo. We found that l-dopa, in comparison with risperidone, impaired performance in a highly specific way, which corresponded to the pattern of patients with reality confusion. Specifically, they had an increase of false positive responses, while overall memory performance and reaction times were unaffected. We conclude that dopaminergic transmission influences the ability to rapidly adapt thinking to ongoing reality.
Adult, Male, Dopamine Agents/*pharmacology, 616.8, Cognition Disorders/chemically induced/*metabolism/physiopathology, Dopamine, Dopamine Agents, Neural Inhibition/drug effects/physiology, Dopamine/*metabolism, Memory Disorders/chemically induced/metabolism/physiopathology, Mental Processes/drug effects/physiology, Neuropsychological Tests, Risperidone/pharmacology, Psychoses, Substance-Induced, Levodopa, Mental Processes, Psychoses, Substance-Induced/*metabolism/physiopathology, Double-Blind Method, Memory, Adaptation, Psychological, Adaptation, Psychological/drug effects/physiology, Brain/drug effects/*metabolism/physiopathology, Humans, Memory Disorders, Brain, Neural Inhibition, Risperidone, Dopamine Antagonists/pharmacology, Memory/drug effects/physiology, Dopamine Antagonists, Cognition Disorders, Levodopa/pharmacology, ddc: ddc:616.8
Adult, Male, Dopamine Agents/*pharmacology, 616.8, Cognition Disorders/chemically induced/*metabolism/physiopathology, Dopamine, Dopamine Agents, Neural Inhibition/drug effects/physiology, Dopamine/*metabolism, Memory Disorders/chemically induced/metabolism/physiopathology, Mental Processes/drug effects/physiology, Neuropsychological Tests, Risperidone/pharmacology, Psychoses, Substance-Induced, Levodopa, Mental Processes, Psychoses, Substance-Induced/*metabolism/physiopathology, Double-Blind Method, Memory, Adaptation, Psychological, Adaptation, Psychological/drug effects/physiology, Brain/drug effects/*metabolism/physiopathology, Humans, Memory Disorders, Brain, Neural Inhibition, Risperidone, Dopamine Antagonists/pharmacology, Memory/drug effects/physiology, Dopamine Antagonists, Cognition Disorders, Levodopa/pharmacology, ddc: ddc:616.8
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 22 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
